Lars Møller Pedersen

Lars Møller Pedersen serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. His clinical specialization is in Internal Medicine with a specific focus on Haematology. He maintains professional affiliations at two locations: Køgevej 7-13 in Roskilde (4000) and Blegdamsvej 3 in Copenhagen North (2200 N).

Dr. Pedersen's research program centers on hematological malignancies with particular emphasis on lymphoma subtypes including Diffuse Large B-Cell Lymphoma (DLBCL), Waldenström macroglobulinemia, and rare presentations of lymphoma in unusual anatomical sites such as salivary glands. His scholarly work frequently employs large-scale Danish nationwide cohort studies to examine epidemiology, treatment outcomes, and risk factors associated with various hematological cancers. He has made significant contributions to understanding central nervous system involvement in lymphoma, relapse patterns following initial treatment, and the prognostic impact of specific genetic mutations on patient outcomes.

Analysis of his recent publications reveals a consistent pattern of clinically relevant research addressing practical questions in hematology oncology. A distinctive feature of his work is the investigation of rare manifestations and complications of lymphoma, including secondary CNS lymphoma, extramedullary disease in Waldenström macroglobulinemia, and lymphoma presentations in salivary glands. His research often evaluates the effectiveness of clinical protocols, particularly regarding follow-up strategies, CNS prophylaxis, and risk stratification approaches for patients with various lymphoma subtypes.

Dr. Pedersen maintains an extensive collaborative network with researchers across Denmark, participating in numerous multi-center studies examining various aspects of hematological malignancies. His work has garnered attention across academic platforms with citations in multiple publications, mentions in news outlets, and engagement on social media platforms including X (formerly Twitter), where several of his publications have been shared by dozens of users.